ANTIDEPRESSANT MAY GET EXPANDED WARNING LABELS

FEBRUARY 01, 2007

A federal advisory panel has recommended that the FDA update black box warnings on antidepressants to include an increased risk of suicide for adults under 25. The drugs have included a black box warning about the increased risk of suicidal thoughts and actions in children and adolescents since 2004.

The panel also advised the agency to add language to the black box warning highlighting the dangers of untreated depression. Thomas Laughren, MD, director of the FDA's division of psychiatry products, said the agency is leaning toward expanding the black box warning to include young adults. Officials also said they will try to use language to encourage health care practitioners to prescribe the drugs carefully. The FDA is in a difficult position, because it does not want the warning to lead physicians to stop prescribing the medications.




SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.